Product Specification
| Alternative Name: | Interleukin-33, NF-HEV, IL-1F11 |
| |
| Concentration: | 0.25mg/ml |
| |
| Purity Detail: | Purified using Ni-NTA column and FPLC. |
| |
| Endotoxin Content: | <1.0EU/µg purified protein (LAL test) |
| |
| Purity: | ≥90% (SDS-PAGE) |
| |
| Formulation: | Liquid. 0.2µm-filtered solution in 55mM TRIS-HCl, pH 8.2, containing 150mM sodium chloride. |
| |
| Source/Host: | Produced in E. coli. The mature domain of recombinant human IL-33 (aa 1-270) is fused at the C-terminus to a His-tag. |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Working aliquots are stable for up to 3 months when stored at -20°C. |
| |
| Handling: | After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap. |
| |
| Background / Technical Information: | UniProt ID O95760: IL-33 (human) |
| |
Figure 1. NH2-terminal sequence analysis of Pro-IL-33 (human), (recombinant) (His-tag) (Prod. No. ALX-201-471).
Figure 2. Pull down assay - pull down of Pro-IL-33-His (human) by ST2-Fc (human)Method 5µg of human ST2-Fc, 2µg of each of human pro-IL-33, human IL-33 and human IL-37 (control) and protein A resin were incubated in 0.5ml RIPA buffer overnight at 4°C. The precipitates were separated by SDS-PAGE, electro-transfered onto NC membrane and subjected to immunoblotting with IL-33 (human), mAb (IL3335B).
Please mouse over
General Literature References
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1: C. Cayrol & J.P. Girard; Proc. Nat.l Acad. Sci. USA
106, 9021 (2009),
Abstract;
Full Text
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo: V. Carriere et al.; Proc. Natl. Acad. Sci. USA
104, 282 (2007),
Abstract;
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines: J. Schmitz, et al.; Immunity
23, 479 (2005),
Abstract;
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules: E.S. Baekkevold, et al. ; Am. J. Pathol.
163, 69 (2003),
Abstract;